OptimizeRx Corp (OPRX) › Total AssetsOptimizeRx Corp (OPRX) — Total AssetsAnnual figures by period end, from SEC filings.2010-12-31: $3.75M2011-12-31: $2.89M2012-12-31: $2.18M2013-12-31: $3.95M2014-12-31: $7.03M2015-12-31: $12.31M2016-12-31: $11.48M2017-12-31: $9.76M2018-12-31: $25.05M2019-12-31: $56.64M2020-12-31: $60.33M2021-12-31: $140.99M2022-12-31: $134.65M2023-12-31: $183.37M2024-12-31: $171.17M2025-12-31: $176.92M$176.92M2010-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$176.92M+3.4%2026-03-12Balance as of period end2024-12-31$171.17M-6.7%2026-03-12Balance as of period end2023-12-31$183.37M+36.2%2025-03-20Balance as of period end2022-12-31$134.65M-4.5%2024-04-15Balance as of period end2021-12-31$140.99M+133.7%2023-03-10Balance as of period end2020-12-31$60.33M+6.5%2023-03-10Balance as of period end2019-12-31$56.64M+126.1%2021-03-08Balance as of period end2018-12-31$25.05M+156.6%2020-03-26Balance as of period end2017-12-31$9.76M-14.9%2019-03-12Balance as of period end2016-12-31$11.48M-6.8%2018-03-08Balance as of period end2015-12-31$12.31M+75.2%2017-03-08Balance as of period end2014-12-31$7.03M+77.8%2016-03-15Balance as of period end2013-12-31$3.95M+81.7%2015-09-16Balance as of period end2012-12-31$2.18M-24.8%2014-03-31Balance as of period end2011-12-31$2.89M-22.8%2013-03-12Balance as of period end2010-12-31$3.75M—2012-03-30Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)